Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly vs Every 3 Week Paclitaxel Liposome in Metastatic Breast Cancer
NCT02142790Phase 4Unknown
- Sponsor
- Luye Pharma Group
- Start
- May 2014
- Primary completion
- Jun 2016
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal paclitaxel in breast cancer, sponsored by Luye Pharma Group. Status: unknown.
02
Drugs
liposomal paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02142790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142790.